Skip to main content

Sleep Apnea Syndrome

0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

ResMed
ResMedSAN DIEGO, CA
2 programs
Standard follow-upN/A1 trial
polygraphy and ECGN/A1 trial
Active Trials
NCT02517346Completed100Est. Dec 2015
NCT02317848Completed54Est. May 2019
Ipsen
IpsenChina - Tianjin
1 program
Diagnosis of acromegalyN/A1 trial
Active Trials
NCT02789696Completed880Est. May 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
ResMedStandard follow-up
ResMedpolygraphy and ECG
IpsenDiagnosis of acromegaly

Clinical Trials (3)

Total enrollment: 1,034 patients across 3 trials

NCT02517346ResMedStandard follow-up

Efficacy of Telemonitoring on CPAP Treatment Compliance in Obstructive Sleep Apnea (OSA) Patients

Start: Jan 2015Est. completion: Dec 2015100 patients
N/ACompleted
NCT02317848ResMedpolygraphy and ECG

PRevalence, Persistence and prOgnostic ValuE of Sleep Apnea Syndrome in Acute Heart Failure

Start: Dec 2014Est. completion: May 201954 patients
N/ACompleted
NCT02789696IpsenDiagnosis of acromegaly

Prevalence of Acromegaly in a Diagnostic Consultation for Sleep Apnea Syndrome

Start: Nov 2013Est. completion: May 2016880 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.